Literature DB >> 27496002

Optogenetic Approaches for Controlling Seizure Activity.

Jack K Tung1, Ken Berglund2, Robert E Gross3.   

Abstract

Optogenetics, a technique that utilizes light-sensitive ion channels or pumps to activate or inhibit neurons, has allowed scientists unprecedented precision and control for manipulating neuronal activity. With the clinical need to develop more precise and effective therapies for patients with drug-resistant epilepsy, these tools have recently been explored as a novel treatment for halting seizure activity in various animal models. In this review, we provide a detailed and current summary of these optogenetic approaches and provide a perspective on their future clinical application as a potential neuromodulatory therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy; Neuromodulation; Optogenetics

Mesh:

Year:  2016        PMID: 27496002      PMCID: PMC5143193          DOI: 10.1016/j.brs.2016.06.055

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  115 in total

1.  An optogenetic toolbox designed for primates.

Authors:  Ilka Diester; Matthew T Kaufman; Murtaza Mogri; Ramin Pashaie; Werapong Goo; Ofer Yizhar; Charu Ramakrishnan; Karl Deisseroth; Krishna V Shenoy
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 2.  Vagus-nerve stimulation for the treatment of epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Lancet Neurol       Date:  2002-12       Impact factor: 44.182

3.  Multimodal fast optical interrogation of neural circuitry.

Authors:  Feng Zhang; Li-Ping Wang; Martin Brauner; Jana F Liewald; Kenneth Kay; Natalie Watzke; Phillip G Wood; Ernst Bamberg; Georg Nagel; Alexander Gottschalk; Karl Deisseroth
Journal:  Nature       Date:  2007-04-05       Impact factor: 49.962

Review 4.  Mouse transgenic approaches in optogenetics.

Authors:  Hongkui Zeng; Linda Madisen
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

5.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Optogenetic activation of superior colliculus neurons suppresses seizures originating in diverse brain networks.

Authors:  Colin Soper; Evan Wicker; Catherine V Kulick; Prosper N'Gouemo; Patrick A Forcelli
Journal:  Neurobiol Dis       Date:  2015-12-23       Impact factor: 5.996

7.  Challenges in the surgical treatment of epilepsy patients with cortical dysplasia.

Authors:  Gary W Mathern
Journal:  Epilepsia       Date:  2009-10       Impact factor: 5.864

8.  Economic impact of epilepsy in the United States.

Authors:  Dokyoung Yoon; Kevin D Frick; Deborah A Carr; Joan K Austin
Journal:  Epilepsia       Date:  2009-06-08       Impact factor: 5.864

9.  Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury.

Authors:  Jeanne T Paz; Thomas J Davidson; Eric S Frechette; Bruno Delord; Isabel Parada; Kathy Peng; Karl Deisseroth; John R Huguenard
Journal:  Nat Neurosci       Date:  2012-11-07       Impact factor: 24.884

10.  Optogenetic acidification of synaptic vesicles and lysosomes.

Authors:  Benjamin R Rost; Franziska Schneider; M Katharina Grauel; Christian Wozny; Claudia Bentz; Anja Blessing; Tanja Rosenmund; Thomas J Jentsch; Dietmar Schmitz; Peter Hegemann; Christian Rosenmund
Journal:  Nat Neurosci       Date:  2015-11-09       Impact factor: 24.884

View more
  8 in total

1.  Theoretical optimization of high-frequency optogenetic spiking of red-shifted very fast-Chrimson-expressing neurons.

Authors:  Neha Gupta; Himanshu Bansal; Sukhdev Roy
Journal:  Neurophotonics       Date:  2019-04-11       Impact factor: 3.593

2.  Chemically activated luminopsins allow optogenetic inhibition of distributed nodes in an epileptic network for non-invasive and multi-site suppression of seizure activity.

Authors:  Jack K Tung; Fu Hung Shiu; Kevin Ding; Robert E Gross
Journal:  Neurobiol Dis       Date:  2017-09-18       Impact factor: 5.996

Review 3.  Applications of optogenetic and chemogenetic methods to seizure circuits: Where to go next?

Authors:  Patrick A Forcelli
Journal:  J Neurosci Res       Date:  2017-08-09       Impact factor: 4.164

4.  Step-function luminopsins for bimodal prolonged neuromodulation.

Authors:  Ken Berglund; Alejandra M Fernandez; Claire-Anne N Gutekunst; Ute Hochgeschwender; Robert E Gross
Journal:  J Neurosci Res       Date:  2019-04-07       Impact factor: 4.164

5.  Photolysis of Caged-GABA Rapidly Terminates Seizures In Vivo: Concentration and Light Intensity Dependence.

Authors:  Dan Wang; Zhixin Yu; Jiaqing Yan; Fenqin Xue; Guoping Ren; Chenxi Jiang; Weimin Wang; Yueshan Piao; Xiaofeng Yang
Journal:  Front Neurol       Date:  2017-05-18       Impact factor: 4.003

Review 6.  Technological Challenges in the Development of Optogenetic Closed-Loop Therapy Approaches in Epilepsy and Related Network Disorders of the Brain.

Authors:  Bram Vandekerckhove; Jeroen Missinne; Kristl Vonck; Pieter Bauwens; Rik Verplancke; Paul Boon; Robrecht Raedt; Jan Vanfleteren
Journal:  Micromachines (Basel)       Date:  2020-12-31       Impact factor: 2.891

Review 7.  Specificity, Versatility, and Continual Development: The Power of Optogenetics for Epilepsy Research.

Authors:  Zoé Christenson Wick; Esther Krook-Magnuson
Journal:  Front Cell Neurosci       Date:  2018-06-14       Impact factor: 5.505

Review 8.  Gene Therapy for Parkinson's Disease, An Update.

Authors:  Tobias M Axelsen; David P D Woldbye
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.